Literature DB >> 12404120

The C-terminal moiety of HIV-1 Vpr induces cell death via a caspase-independent mitochondrial pathway.

T Roumier1, H L A Vieira, M Castedo, K F Ferri, P Boya, K Andreau, S Druillennec, N Joza, J M Penninger, B Roques, G Kroemer.   

Abstract

Previous biochemical studies suggested that HIV-1-encoded Vpr may kill cells through an effect on the adenine nucleotide translocase (ANT), thereby causing mitochondrial membrane permeabilization (MMP). Here, we show that Vpr fails to activate caspases in conditions in which it induces cell killing. The knock-out of essential caspase-activators (Apaf-1 or caspase-9) or the knock-out of a mitochondrial caspase-independent death effector (AIF) does not abolish Vpr-mediated killing. In contrast, the cytotoxic effects of Vpr are reduced by transfection-enforced overexpression of two MMP-inhibitors, namely the endogenous protein Bcl-2 or the cytomegalovirus-encoded ANT-targeted protein vMIA. Vpr, which can elicit MMP through a direct effect on mitochondria, and HIV-1-Env, which causes MMP through an indirect pathway, exhibit additive (but not synergic) cytotoxic effects. In conclusion, it appears that Vpr induces apoptosis through a caspase-independent mitochondrial pathway.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12404120     DOI: 10.1038/sj.cdd.4401089

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  25 in total

1.  The influenza A virus PB1-F2 protein targets the inner mitochondrial membrane via a predicted basic amphipathic helix that disrupts mitochondrial function.

Authors:  James S Gibbs; Daniela Malide; Felicita Hornung; Jack R Bennink; Jonathan W Yewdell
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

2.  Human immunodeficiency virus type 1 Vpr interacts with antiapoptotic mitochondrial protein HAX-1.

Authors:  Venkat S R K Yedavalli; Hsiu-Ming Shih; Yu-Ping Chiang; Chun-Yi Lu; Luan-Yin Chang; Mao-Yuan Chen; Che-Yen Chuang; Andrew I Dayton; Kuan-Teh Jeang; Li-Min Huang
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

Review 3.  HIV-1 Vpr: mechanisms of G2 arrest and apoptosis.

Authors:  Joshua L Andersen; Erwann Le Rouzic; Vicente Planelles
Journal:  Exp Mol Pathol       Date:  2008-04-25       Impact factor: 3.362

4.  Induction of apoptosis limits cytomegalovirus cross-species infection.

Authors:  Igor Jurak; Wolfram Brune
Journal:  EMBO J       Date:  2006-05-11       Impact factor: 11.598

5.  Experimental confirmation of global murine cytomegalovirus open reading frames by transcriptional detection and partial characterization of newly described gene products.

Authors:  Qiyi Tang; Eain A Murphy; Gerd G Maul
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

Review 6.  Protein intrinsic disorder as a flexible armor and a weapon of HIV-1.

Authors:  Bin Xue; Marcin J Mizianty; Lukasz Kurgan; Vladimir N Uversky
Journal:  Cell Mol Life Sci       Date:  2011-10-28       Impact factor: 9.261

7.  Analysis of human immunodeficiency virus cytopathicity by using a new method for quantitating viral dynamics in cell culture.

Authors:  Christina Speirs; Erik van Nimwegen; Diane Bolton; Mihaela Zavolan; Melody Duvall; Sara Angleman; Richard Siegel; Alan S Perelson; Michael J Lenardo
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

8.  Critical implication of the (70-96) domain of human immunodeficiency virus type 1 Vpr protein in apoptosis of primary rat cortical and striatal neurons.

Authors:  Emmanuelle N Sabbah; Bernard P Roques
Journal:  J Neurovirol       Date:  2005-12       Impact factor: 2.643

Review 9.  Vpr-host interactions during HIV-1 viral life cycle.

Authors:  Richard Y Zhao; Ge Li; Michael I Bukrinsky
Journal:  J Neuroimmune Pharmacol       Date:  2011-02-12       Impact factor: 4.147

10.  Virion-associated Vpr of human immunodeficiency virus type 1 triggers activation of apoptotic events and enhances fas-induced apoptosis in human T cells.

Authors:  Hubert Arokium; Masakazu Kamata; Irvin Chen
Journal:  J Virol       Date:  2009-08-19       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.